1-3 of 3
glucosylceramide synthase inhibitors
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glucose Ceramide Synthase Inhibitors Inhibit Osteoclast Activation Induced by Myeloma-Derived and De Novo Synthesized Glycosphingolipids.

Ke Xu, MD, Aristotelis Antonopoulos, PhD, Emmanouil Spanoudakis, MD, PhD, Simon Parry, PhD, Aristeidis Chaidos, MD, PhD, Ming Hu, PhD, Terry Butters, PhD, Anne Dell, PhD, Amin Rahemtulla, MBBS, PhD, FRCP, Nikki Horwood, PhD, Anastasios Karadimitris, PhD, MRCP, FRCPath
Journal: Blood
Blood (2009) 114 (22): 424.
https://doi.org/10.1182/blood.V114.22.424.424
Published: 2009
Journal Articles

Effect of PDMP, a Glucosylceramide Synthase Inhibitor, On Resistance to Daunorubicin in Human Leukemia Cell Line K562/A02.

Bao-An Chen, Li Yin, Jian Cheng, Jia-hua Ding, Chong Gao, Gang Zhao, Jun Wang, Guo-hua Xia, Ning-Na Chen, Xiao-Ping Pei
Journal: Blood
Blood (2009) 114 (22): 4821.
https://doi.org/10.1182/blood.V114.22.4821.4821
Published: 2009
Journal Articles

Glucosylceramide Synthetase Inhibitors Sensitise B-CLL Cells to Cytotoxic Agents without Reversing P-gp Functional Activity.

Gareth Gerrard, MSc, Terry D. Butters, PhD, Atul B. Mehta, MD, A. Victor Hoffbrand, DSc, Derryln Hughes, MD, Michael Burgess, MD, Kanagasabai Ganeshaguru, PhD
Journal: Blood
Blood (2004) 104 (11): 1181.
https://doi.org/10.1182/blood.V104.11.1181.1181
Published: 2004